Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Psychopharmacology

• Publication date

  2005-01-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00213-004-2065-6PMID 15672275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of postsynaptic calcium in the induction of long-term potentiation

  2008cited by this paper
• Structure-based rational design of chemical ligands for AMPA-subtype glutamate receptors

  2007cited by this paper
• LY404187: a novel positive allosteric modulator of AMPA receptors.

  2006influential reference
• Aniracetam: its novel therapeutic potential in cerebral dysfunctional disorders based on recent pharmacological discoveries.

  2006cited by this paper
• Modulation of AMPA receptor kinetics differentially influences synaptic plasticity in the hippocampus.

  2004influential reference
• Selective Expression of Heteromeric AMPA Receptors Driven by Flip–Flop Differences

  2004influential reference
• NMDA-antagonism (memantine): an alternative pharmacological therapeutic principle in Alzheimer's and vascular dementia.

  2004cited by this paper
• Expression of transcripts encoding AMPA receptor subunits and associated postsynaptic proteins in the macaque brain

  2004cited by this paper
• Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease.

  2004cited by this paper
• Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents

  2004cited by this paper
• Critical role of brain-derived neurotrophic factor in mood disorders.

  2004cited by this paper
• The effects of IDRA 21, a positive modulator of the AMPA receptor, on delayed matching performance by young and aged rhesus monkeys.

  2004influential reference
• The NMDA receptor NR2B subunit: a valid therapeutic target for multiple CNS pathologies.

  2004cited by this paper
• AMPA receptor modulators as cognitive enhancers.

  2004cited by this paper
• Chronic Elevation of Brain-Derived Neurotrophic Factor by Ampakines

  2003cited by this paper
• AMPA receptor trafficking and long-term potentiation.

  2003influential reference
• Regional specific increases of [3H]AMPA binding and mRNA expression of AMPA receptors in the brain of mu-opioid receptor knockout mice.

  2003influential reference
• Recent advances in the study of AMPA receptors.

  2003cited by this paper
• LY503430, a Novel α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Potentiator with Functional, Neuroprotective and Neurotrophic Effects in Rodent Models of Parkinson's Disease

  2003cited by this paper
• LY 503430 , a Novel-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Potentiator with Functional , Neuroprotective and Neurotrophic Effects in Rodent Models of Parkinson ’ s Disease

  2003cited by this paper
• LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.

  2003cited by this paper
• Synaptic Plasticity and AMPA Receptor Trafficking

  2003influential reference
• Therapeutic N-methyl-D-aspartate receptor antagonists: will reality meet expectation?

  2003cited by this paper
• Multiple Molecular Determinants for Allosteric Modulation of Alternatively Spliced AMPA Receptors

  2003cited by this paper
• Positive allosteric modulators of AMPA receptors are neuroprotective against lesions induced by an NMDA agonist in neonatal mouse brain.

  2003cited by this paper
• GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery?

  2003cited by this paper
• Aniracetam enhances glutamatergic transmission in the prefrontal cortex of stroke-prone spontaneously hypertensive rats.

  2002cited by this paper
• Effects of single or repeated restraint stress on GluR1 and GluR2 flip and flop mRNA expression in the hippocampal formation.

  2002influential reference
• Preliminary experience with an ampakine (CX516) as a single agent for the treatment of schizophrenia: a case series.

  2002cited by this paper
• Structure-based functional design of chemical ligands for AMPA-subtype glutamate receptors

  2002cited by this paper
• Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model.

  2002cited by this paper
• An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study.

  2002cited by this paper
• A new benzodiazepine pharmacology.

  2002cited by this paper
• Selective Alterations in Ionotropic Glutamate Receptors in the Anterior Cingulate Cortex in Schizophrenia

  2002cited by this paper
• NMDA receptor pharmacology: perspectives from molecular biology.

  2001cited by this paper
• Antidepressant-like effects of aniracetam in aged rats and its mode of action

  2001cited by this paper
• Pharmacological effects of AMPA receptor potentiators LY392098 and LY404187 on rat neuronal AMPA receptors in vitro.

  2001cited by this paper
• Mechanism and impact of allosteric AMPA receptor modulation by the ampakine CX546.

  2001cited by this paper
• The AMPA receptor allosteric potentiator PEPA ameliorates post-ischemic memory impairment

  2001cited by this paper
• NMDA receptor subunits: diversity, development and disease.

  2001cited by this paper
• Role of ampa receptor endocytosis in synaptic plasticity

  2001cited by this paper
• Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.

  2001cited by this paper
• Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism.

  2001cited by this paper
• Effects of intrahippocampal aniracetam treatment on Y-maze avoidance learning performance and behavioral long-term potentiation in dentate gyrus in rat.

  2001cited by this paper
• A Placebo-Controlled Pilot Study of the Ampakine CX516 Added to Clozapine in Schizophrenia

  2001cited by this paper
• Positive Modulation of α-Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid (AMPA) Receptors in Prefrontal Cortical Pyramidal Neurons by a Novel Allosteric Potentiator

  2001influential reference
• Intra- and interstrain differences in models of "behavioral despair".

  2001cited by this paper
• Potentiation of responses to AMPA on central neurones by LY392098 and LY404187 in vivo.

  2001cited by this paper
• Expression of AMPA Receptor Flip and Flop mRNAs in the Nucleus Accumbens and Prefrontal Cortex after Neonatal Ventral Hippocampal Lesions

  2001influential reference
• Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro.

  2001cited by this paper
• Effect of AMPA receptor modulators on hippocampal and cortical function.

  2000cited by this paper
• Impulsivity and AMPA receptors: aniracetam ameliorates impulsive behavior induced by a blockade of AMPA receptors in rats.

  2000cited by this paper
• Regulation of Kinetic Properties of GluR2 AMPA Receptor Channels by Alternative Splicing

  2000cited by this paper
• Glutamate receptor expression in schizophrenic brain.

  2000cited by this paper
• Positive Modulation of AMPA Receptors Increases Neurotrophin Expression by Hippocampal and Cortical Neurons

  2000cited by this paper
• Neurotrophic factors in Alzheimer's and Parkinson's disease brain.

  2000cited by this paper
• NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice.

  2000cited by this paper
• Sustained ethanol inhibition of native AMPA receptors on medial septum/diagonal band (MS/DB) neurons

  2000influential reference
• Serotonergic mechanisms involved in the attentional and vigilance task performance of rats and the palliative action of aniracetam

  2000cited by this paper
• The AMPA receptor interacts with and signals through the protein tyrosine kinase Lyn

  1999cited by this paper
• Interactive effects of subanesthetic ketamine and haloperidol in healthy humans

  1999cited by this paper
• Flip and flop variants of AMPA receptor subunits in the human cerebellum: Implication for the selective vulnerability of purkinje cells

  1999cited by this paper
• The role of excitotoxicity in neurodegenerative disease: implications for therapy.

  1999cited by this paper
• NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders.

  1999cited by this paper
• NMDA receptor hypofunction model of schizophrenia.

  1999cited by this paper
• Synergistic interactions between ampakines and antipsychotic drugs.

  1999cited by this paper
• Glutamatergic and dopaminergic afferents to the prefrontal cortex regulate spatial working memory in rats.

  1999cited by this paper
• The role of excitotoxicity in neurodegenerative disease: implications for therapy.

  1999cited by this paper
• Involvement of cholinergic and GABAergic systems in the reversal of memory disruption by NS-105, a cognition enhancer.

  1999cited by this paper
• Apomorphine-induced hypoattention in rats and reversal of the choice performance impairment by aniracetam.

  1998cited by this paper
• Expression of messenger RNAs encoding ionotropic glutamate receptors in rat brain: regulation by haloperidol.

  1998cited by this paper
• Scopolamine model of delirium in rats and reversal of the performance impairment by aniracetam

  1998cited by this paper
• Modulating excitatory synaptic neurotransmission: potential treatment for neurological disease?

  1998cited by this paper
• Regional preferences of AMPA receptor modulators determined through agonist binding autoradiography.

  1998cited by this paper
• Facilitative Effects of the Ampakine CX516 on Short-Term Memory in Rats: Correlations with Hippocampal Neuronal Activity

  1998influential reference
• Facilitative Effects of the Ampakine CX516 on Short-Term Memory in Rats: Enhancement of Delayed-Nonmatch-to-Sample Performance

  1998influential reference
• AMPA Receptor Facilitation Accelerates Fear Learning without Altering the Level of Conditioned Fear Acquired

  1997cited by this paper
• Enhancement by an ampakine of memory encoding in humans.

  1997influential reference
• Synchronization processes in the mechanisms of short-term memory in monkeys: The involvement of cholinergic and glutaminergic cortical structures

  1997cited by this paper
• A profile of the behavioral changes produced by facilitation of AMPA-type glutamate receptors

  1997cited by this paper
• Evidence that a positive modulator of AMPA-type glutamate receptors improves delayed recall in aged humans.

  1997cited by this paper
• GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: a reverse transcriptase-polymerase chain reaction (RT-PCR) study.

  1997cited by this paper
• Stable Expression of Recombinant AMPA Receptor Subunits: Binding Affinities and Effects of Allosteric Modulators

  1997cited by this paper
• Effects of D-cycloserine and aniracetam on spatial learning in rats with entorhinal cortex lesions.

  1997cited by this paper
• Effects of AMPA receptor positive modulators on amphetamine- and dizocilpine-induced locomotion.

  1997cited by this paper
• AMPA receptor agonists, antagonists and modulators: their potential for clinical utility

  1997cited by this paper
• Prefrontal function in schizophrenia: confounds and controversies.

  1996influential reference
• Psychological effects of a drug that facilitates brain AMPA receptors

  1996cited by this paper
• Effects of an AMPA receptor modulator on methamphetamine-induced hyperactivity in rats.

  1996cited by this paper
• Effect of the AMPA receptor modulator IDRA 21 on LTP in hippocampal slices

  1996influential reference
• Correlation between kinetics and RNA splicing of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in neocortical neurons.

  1996cited by this paper
• The role of the prefrontal cortex in higher cognitive functions.

  1996cited by this paper
• New developments in the molecular pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate and kainate receptors.

  1996influential reference
• Splice variants of glutamate receptor subunits 2 and 3 in striatal projection neurons.

  1996cited by this paper
• Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS.

  1995influential reference
• 7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide (IDRA 21), a congener of aniracetam, potently abates pharmacologically induced cognitive impairments in patas monkeys.

  1995cited by this paper
• Enhanced glutamatergic neurotransmission facilitates classical conditioning in the freely moving rat.

  1995cited by this paper
• Synaptic excitation mediated by AMPA receptors in rat cerebellar slices is selectively enhanced by aniracetam and cyclothiazide

  1995cited by this paper
• Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.

  1995cited by this paper
• 7-Chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating DL-alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitization.

  1995cited by this paper

• Shared genetic underpinnings of gray matter volume alterations and metabolic traits in major depressive disorder.

  2026cites this paper
• Aniracetam restores the excitation-inhibition balance of neurotransmitters in the prefrontal cortex of mice with ADHD

  2026cites this paper
• Structural Exploration around 4-Cyclopropyl-Substituted 1,2,4-Benzothiadiazine 1,1-Dioxides: Impact of the Dihalo-Substitution of the Benzene Ring on α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Receptor Potentiation.

  2025cites this paper
• Aniracetam Ameliorates Attention Deficit Hyperactivity Disorder Behavior in Adolescent Mice

  2025cites this paper
• Oligomeric alpha-synuclein causes early synaptic dysfunction of the corticostriatal pathway associated with non-motor symptoms

  2025cites this paper
• Positive allosteric modulation of AMPA receptors via PF4778574 leads to reduced demyelination and clinical disability in experimental models of multiple sclerosis

  2025cites this paper
• Positive AMPA and Kainate Receptor Modulators and Their Therapeutic Potential in CNS Diseases: A Comprehensive Review

  2025influential citation
• Drugs with glutamate-based mechanisms of action in psychiatry

  2024cites this paper
• Repurposing General Anesthetic Drugs to Treat Depression: A New Frontier for Anesthesiologists in Neuropsychiatric Care.

  2024cites this paper
• Targeting synapse function and loss for treatment of neurodegenerative diseases

  2023cites this paper
• Treating early postnatal circuit defect delays Huntington’s disease onset and pathology in mice

  2022cites this paper
• A Novel Phenylpyrrolidine Derivative: Synthesis and Effect on Cognitive Functions in Rats with Experimental Ishemic Stroke

  2021cites this paper
• Spectroscopic studies, quantum chemical investigations, and in silico and in vitro scrutiny of the diuretic drug trichlormethiazide adsorbed on AuNPs

  2021cites this paper
• Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels

  2021cites this paper
• Targeting the Pancreatic α-Cell to Prevent Hypoglycemia in Type 1 Diabetes

  2021cites this paper
• Strictly regulated agonist-dependent activation of AMPA-R is the key characteristic of TAK-653 for robust synaptic responses and cognitive improvement

  2021cites this paper
• Neuroimaging of Supraventricular Frontal White Matter in Children with Familial Attention-Deficit Hyperactivity Disorder and Attention-Deficit Hyperactivity Disorder Due to Prenatal Alcohol Exposure

  2021cites this paper
• Acetylation of AMPA Receptors Regulates Receptor Trafficking and Rescues Memory Deficits in Alzheimer's Disease

  2020cites this paper
• Allosteric modulation of AMPA receptors counteracts Tau-related excitotoxic synaptic signaling and memory deficits in stress- and Aβ-evoked hippocampal pathology

  2020cites this paper
• Characterization of a new positive allosteric modulator of AMPA receptors - PAM-43: specific binding of the ligand and its ability to potentiate AMPAR currents.

  2020cites this paper
• Auxiliary Proteins are the Predominant Determinants of Differential Efficacy of Clinical Candidates Acting as AMPA Receptor Positive Allosteric Modulators

  2020cites this paper
• Pharmacological characterisation of MDI-222, a novel AMPA receptor positive allosteric modulator with an improved safety profile

  2019cites this paper
• mGlu2/3 receptor antagonists.

  2019cites this paper
• Keeping up with the clinical advances: depression

  2019cites this paper
• Amyotrophic lateral sclerosis.

  2019cites this paper
• Positive Allosteric Modulation of AMPAR by PF-4778574 Produced Rapid Onset Antidepressant Actions in Mice.

  2018cites this paper
• Genetic variation of GRIA3 gene is associated with vulnerability to methamphetamine dependence and its associated psychosis

  2018cites this paper
• Positron Emission Tomography (PET) Ligand Development for Ionotropic Glutamate Receptors: Challenges and Opportunities for Radiotracer Targeting N-Methyl-d-aspartate (NMDA), α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA), and Kainate Receptors.

  2018cites this paper
• Pregenual Anterior Cingulate Dysfunction Associated with Depression in OCD: An Integrated Multimodal fMRI/1H MRS Study

  2018cites this paper
• The reduction in glutamate release is predictive of cognitive and emotional alterations that are corrected by the positive modulator of AMPA receptors S 47445 in perinatal stressed rats

  2018cites this paper
• Designing a Formulation of the Nootropic Drug Aniracetam Using 2-Hydroxypropyl-β-Cyclodextrin Suitable for Parenteral Administration

  2018cites this paper
• AMPA‐induced extracellular Zn2+ influx into nigral dopaminergic neurons causes movement disorder in rats

  2018cites this paper
• Modulating AMPA Receptors for the Treatment of CNS Disorders

  2017cites this paper
• Attenuation of ketamine-induced impairment in verbal learning and memory in healthy volunteers by the AMPA receptor potentiator PF-04958242

  2017cites this paper
• S 47445 Produces Antidepressant- and Anxiolytic-Like Effects through Neurogenesis Dependent and Independent Mechanisms

  2017cites this paper
• Long-lasting bio-behavioural effects of early-life sildenafil administration in stress-sensitive versus healthy control rats

  2017cites this paper
• Synergistic enhancing-memory effect of donepezil and S 47445, an AMPA positive allosteric modulator, in middle-aged and aged mice

  2017cites this paper
• Methylphenidate modifies the motion of the circadian clock Lamotrigine in mood disorders and cocaine dependence Cortical glutamate in postpartum depression Pregenual Anterior Cingulate Dysfunction Associated with Depression in OCD : An Integrated Multimodal fMRI / 1 H MRS Study

  2017cites this paper
• Receptor Targets in Alzheimer’s Disease Drug Discovery

  2017cites this paper
• Pharmacological characterisation of S 47445, a novel positive allosteric modulator of AMPA receptors

  2017cites this paper
• Ionotropic Glutamate Receptor Technologies

  2016cites this paper
• Current Recording and Kinetic Analyses for Single AMPA Receptors

  2016cites this paper
• Ampakine CX717 potentiates intermittent hypoxia-induced hypoglossal long-term facilitation.

  2016cites this paper
• Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders.

  2016cites this paper
• AMPA Receptor Positive Allosteric Modulators: Potential for the Treatment of Neuropsychiatric and Neurological Disorders.

  2016cites this paper
• AMPA receptor desensitization is the determinant of AMPA receptor mediated excitotoxicity in purified retinal ganglion cells.

  2015cites this paper
• The role of 5-HT2C receptors in touchscreen visual reversal learning in the rat: a cross-site study

  2015cites this paper
• The discovery and characterization of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor potentiator N-{(3S,4S)-4-[4-(5-cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242).

  2015cites this paper
• AMPA receptor potentiators: from drug design to cognitive enhancement.

  2015cites this paper
• 1-(1,3-Benzodioxol-5-yl-carbo-nyl) piperidine, a modulator of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor, ameliorates exercise-induced fatigue in mice.

  2014cites this paper
• Age-Dependent Modifications of AMPA Receptor Subunit Expression Levels and Related Cognitive Effects in 3xTg-AD Mice

  2014cites this paper
• Functional insight into development of positive allosteric modulators of AMPA receptors.

  2014cites this paper
• Synthesis, Crystal Structure and Anti-Fatigue Effects of Some Benzamide Derivatives

  2014cites this paper
• Structure of an agonist-bound ionotropic glutamate receptor

  2014cites this paper
• Cognitive Enhancers: Role of the Glutamate System

  2014cites this paper
• Preclinical Evidence of Rapid-Onset Antidepressant-Like Effect in Radix Polygalae Extract

  2014cites this paper
• Synthesis and Structure Determination of 2,3‐Diaryl‐9,9‐dioxo‐1H‐9‐thia‐1,4,4a,7,10‐pentaazaphenanthrene‐2‐ols.

  2013cites this paper
• Glutamate system as target for development of novel antidepressants

  2013cites this paper
• Functional analysis of a novel positive allosteric modulator of AMPA receptors derived from a structure-based drug design strategy.

  2013cites this paper
• X-ray Crystallographic Structures as a Source of Ligand Alignment in 3D-QSAR

  2013cites this paper
• Development of thiophenic analogues of benzothiadiazine dioxides as new powerful potentiators of 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid (AMPA) receptors.

  2013cites this paper
• The neuropsychopharmacology of reversal learning

  2013cites this paper
• Identification of novel modulators for ionotropic glutamate receptor, iGluA2 by in-silico screening

  2013influential citation
• Allosteric modulators for the treatment of schizophrenia: targeting glutamatergic networks.

  2013cites this paper
• Discovery and characterization of a novel dihydroisoxazole class of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor potentiators.

  2013cites this paper
• Positive Allosteric Modulation of AMPA Receptors from Efficacy to Toxicity: The Interspecies Exposure-Response Continuum of the Novel Potentiator PF-4778574

  2013influential citation
• The AMPA receptor modulator S18986 in the prelimbic cortex enhances acquisition and retention of an odor-reward association.

  2013cites this paper
• Novel routes to bipolar disorder drug discovery

  2013cites this paper
• Are AMPA Receptor Positive Allosteric Modulators Potential Pharmacotherapeutics for Addiction?

  2013cites this paper
• 5-Arylbenzothiadiazine Type Compounds as Positive Allosteric Modulators of AMPA/Kainate Receptors.

  2012cites this paper
• Regioselective cyclization of chloroacylaminobenzenesulfonamide derivatives

  2012cites this paper
• Efficient synthesis of 5,6-dihydro-8H-[1,2,4]thiadiazino[6,5,4-de]phenanthridine 4,4-dioxide and 5,6-dihydro-8H-[1,2,4]-thiadiazino[6,5,4-ij]thieno[2,3-c]quinoline 4,4-dioxide

  2012cites this paper
• AMPA receptor positive modulators

  2012cites this paper
• Using Simcyp to project human oral pharmacokinetic variability in early drug research to mitigate mechanism‐based adverse events

  2012cites this paper
• Novel glutamatergic agents for major depressive disorder and bipolar disorder.

  2012cites this paper
• Case–control association study of GRIA1, GRIA2 and GRIA4 polymorphisms in bipolar disorder

  2012cites this paper
• Roles of glutamate signaling in preclinical and/or mechanistic models of depression.

  2012cites this paper
• Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder

  2012cites this paper
• Effects of positive modulators of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors in a benzodiazepine-induced deficit of spatial discrimination in mice

  2012cites this paper
• Cyclothiazide‐induced persistent increase in respiratory‐related activity in vitro

  2012cites this paper
• Drug targets for cognitive enhancement in neuropsychiatric disorders.

  2011cites this paper
• Fetal Alcohol Spectrum Disorders and Abnormal Neuronal Plasticity

  2011cites this paper
• Neural circuitry and neuroplasticity in mood disorders: Insights for novel therapeutic targets

  2011cites this paper
• Molecular modeling studies, synthesis, configurational stability and biological activity of 8-chloro-2,3,5,6-tetrahydro-3,6-dimethyl-pyrrolo[1,2,3-de]-1,2,4-benzothiadiazine 1,1-dioxide.

  2011cites this paper
• Emerging drugs for schizophrenia

  2011cites this paper
• Development of Brain Monoaminergic Systems

  2011cites this paper
• The treatment of cognitive impairment in schizophrenia.

  2011cites this paper
• The effects of huperzine A and IDRA 21 on visual recognition memory in young macaques.

  2011cites this paper
• A new phenylalanine derivative acts as an antagonist at the AMPA receptor GluA2 and introduces partial domain closure: synthesis, resolution, pharmacology, and crystal structure.

  2011cites this paper
• Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments

  2011cites this paper
• Microsoft Word-87370388-file00

  2011cites this paper
• Structural and Functional Analysis of Two New Positive Allosteric Modulators of GluA2 Desensitization and Deactivation

  2011cites this paper
• Behavioral neurobiology of bipolar disorder and its treatment

  2011cites this paper
• AMPA Receptor Regulation at the mRNA and Protein Level in Rat Primary Cortical Cultures

  2011cites this paper
• A prospective study of cognitive deficits in first episode psychosis, and the response thereof to treatment with Flupenthixol Decanoate

  2011cites this paper
• Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs

  2011cites this paper
• Understanding The Single Channel Behavior Of Glua3 Receptors

  2011cites this paper
• Novel Therapeutic Approaches for Treating Bipolar Disorder

  2011cites this paper
• Molecular characterization of the AMPA-receptor potentiator S70340 in rat primary cortical culture: whole-genome expression profiling.

  2011cites this paper
• GLUTAMATERGIC DRUGS IN TREATMENT OF SCHIZOPHRENIA A report on relevance

  2011influential citation